Credit Suisse Downgrades Mead Johnson Nutrition (MJN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
JPMorgan Downgrades Mead Johnson Nutrition (MJN) to Neutral
January 17, 2013 8:13 AM ESTJPMorgan downgraded Mead Johnson Nutrition (NYSE: MJN) from Overweight to Neutral with a price target of $68.00 (from $71.00).
NOTE: This is the second downgrade in as many days.
For an analyst ratings summary and ratings history on Mead Johnson Nutrition... More
